Main menu button

Abera Bioscience

Abera Bioscience develops vaccine- and drug candidates for infectious disease and cancer. The technology is based on modified bacterial parts that display selected antigens produced with short lead times.

Initiation of Coverage: 5 December 2022
Sector: Healthcare
Lista : Spotlight
Ticker: ABERA:SS
Niklas Elmhammer
Niklas Elmhammer LinkedIn
Senior Equity Analyst